VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 143 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,000 | +87.5% | 1,416 | +95.6% | 0.00% | – |
| Q1 2022 | $8,000 | -33.3% | 724 | -3.7% | 0.00% | – |
| Q4 2021 | $12,000 | 0.0% | 752 | +5.8% | 0.00% | – |
| Q3 2021 | $12,000 | +71.4% | 711 | +19.9% | 0.00% | -100.0% |
| Q2 2020 | $7,000 | -36.4% | 593 | -44.3% | 0.00% | -80.0% |
| Q1 2020 | $11,000 | +1000.0% | 1,064 | +1734.5% | 0.01% | – |
| Q2 2019 | $1,000 | -94.4% | 58 | -94.1% | 0.00% | -100.0% |
| Q1 2019 | $18,000 | +800.0% | 984 | +720.0% | 0.01% | +250.0% |
| Q4 2017 | $2,000 | +100.0% | 120 | +103.4% | 0.00% | +100.0% |
| Q3 2017 | $1,000 | 0.0% | 59 | +20.4% | 0.00% | 0.0% |
| Q2 2017 | $1,000 | -66.7% | 49 | -77.3% | 0.00% | -66.7% |
| Q4 2016 | $3,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |